- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RF-CWC
Total 1782 results
-
University of Turin, ItalyCompletedMultiple MyelomaItaly
-
National Cancer Institute (NCI)Completed
-
University of BirminghamActive, not recruitingAcute Myeloid Leukemia | MyelodysplasiaUnited Kingdom
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Ann Arbor Stage I Small Lymphocytic Lymphoma | Ann Arbor Stage II Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia... and other conditionsUnited States
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Telix PharmaceuticalsRecruiting
-
Chang Gung Memorial HospitalCompletedMetastatic Prostate CancerTaiwan
-
Wan-Guang ZhangBeiGene; Geneplus-Beijing Co. Ltd.; Simcere Pharmaceutical Co., Ltd; Chinese Cooperative... and other collaboratorsRecruiting
-
University of MinnesotaCompletedAlopecia AreataUnited States
-
Helsinki University Central HospitalUniversity of Helsinki; Academy of FinlandUnknownEnd Stage Renal Failure With Renal TransplantFinland
-
Southeast Retina Center, GeorgiaGenentech, Inc.CompletedPolypoidal Choroidal VasculopathyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditionsUnited States
-
Andrei IagaruCompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | PSA FailureUnited States
-
Affiliated Hospital of Qinghai UniversityRecruitingGastric Cancer | Gastro-oesophageal Junction CancerChina
-
Colgate PalmoliveCompleted
-
Ove AndersenUniversity of CopenhagenCompleted
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedSubacromial Impingement Syndrome | Central SensitisationTurkey (Türkiye)
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Noordwest ZiekenhuisgroepActive, not recruitingPreterm Birth | Developmental Delay | Growth DelayNetherlands
-
Western Galilee Hospital-NahariyaNot yet recruitingLabor Onset and Length Abnormalities | Induced; Birth
-
Fundación Santiago Dexeus FontCompleted
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Spain, United Kingdom, South Korea
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
Colgate PalmoliveCompleted
-
Thomas HopeCompletedProstate CancerUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumActive, not recruiting
-
Federal University of São PauloCompleted
-
Boston Children's HospitalCompletedPain, Postoperative | Numbness | Temperature Sensation | Perception of TouchUnited States
-
Gilead SciencesTerminatedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Peking Union Medical College HospitalActive, not recruiting
-
University of PittsburghBristol-Myers SquibbWithdrawnNon Hodgkin LymphomaUnited States
-
Tabriz University of Medical SciencesSCARM Institute, Tabriz, IranCompleted
-
CelgeneAbbVieTerminatedLeukemia, Myeloid, AcuteUnited States, Canada, France, United Kingdom, Belgium
-
CelgeneCompletedAnemia, Sickle CellUnited States
-
La Jolla Pharmaceutical CompanyCompletedSepsis | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockUnited States
-
Merck Sharp & Dohme LLCCompletedVaccine Response Impaired
-
Chang Gung Memorial HospitalRecruiting
-
CelgeneCompletedRheumatoid ArthritisUnited States
-
Weill Medical College of Cornell UniversityPOINT BiopharmaActive, not recruiting
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
Taipei Veterans General Hospital, TaiwanRecruitingDry Eye Syndrome | XerophthalmiaTaiwan
-
The Lymphoma Academic Research OrganisationCelgeneCompletedRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Roswell Park Cancer InstitutePfizerWithdrawnRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 Positive | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Blasts 5 Percent or More of Peripheral Blood White Cells | Lymphoblasts... and other conditionsUnited States
-
Abbott Medical OpticsCompletedCataractDominican Republic